Human Nutritional Sciences, University of Manitoba, Winnipeg, MB, Canada.
Int J Biochem Cell Biol. 2012 Aug;44(8):1321-30. doi: 10.1016/j.biocel.2012.05.005. Epub 2012 May 15.
Conjugated linoleic acid (CLA), a dietary fat, has been considered beneficial in metabolic syndrome. Despite several findings indicating that CLA improves glucose clearance, little information is available regarding the cellular dynamics of CLA on skeletal muscle. We sought to investigate the role of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in cis-9, trans-11(c9,t11) and trans-10, cis-12 (t10,c12) CLA isomer-mediated glucose transport by L6 myotubes. t10,c12-CLA stimulated both intracellular Ca(2+) release (Ca(i)(2+)) and CaMKII phosphorylation, whereas c9,t11-CLA showed only modest effects on both. Sequestering Ca(i)(2+) with BAPTA/AM abrogated the effect of both CLA isomers on Akt substrate-160 kDa (AS160) phosphorylation and glucose uptake by myotubes. Exposing myotubes to KN-93 or autocamtide 2-related inhibitory peptide to block CaMKII activity prevented both CLA isomers from inducing AS160 phosphorylation and glucose transport. Likewise, genetic knockdown of CaMKII in myotubes using siRNA completely abolished CLA isomer-mediated glucose uptake. These results indicate that CLA isomers require Ca(i)(2+)-CaMKII to mediate glucose uptake. Evidence that CaMKII blockers inhibit t10,c12-CLA-mediated AMP-activated protein kinase (AMPK) activation indicated that CaMKII acts upstream of AMPK in response to t10,c12-CLA. Lastly, CLA isomers stimulated the formation of reactive oxygen species but had no effect on stress-activated protein kinase/c-jun NH(2)-terminal kinase. These data establish that t10,c12-CLA acts via Ca(i)(2+)-CaMKII-AMPK-AS160 to stimulate skeletal muscle glucose transport, whereas the mechanism of c9,t11-CLA remains unclear. Given that impairments in muscle glucose utilisation are apparent in metabolic syndrome, delineating the molecular mechanisms by which CLA isomers mediate muscle glucose uptake may identify new approaches to manage this condition.
共轭亚油酸(CLA)是一种膳食脂肪,被认为对代谢综合征有益。尽管有几项研究表明 CLA 可改善葡萄糖清除率,但关于 CLA 对骨骼肌的细胞动力学影响的信息很少。我们试图研究钙/钙调蛋白依赖性蛋白激酶 II(CaMKII)在 cis-9,trans-11(c9,t11)和 trans-10,cis-12(t10,c12)CLA 异构体介导的 L6 肌管葡萄糖转运中的作用。t10,c12-CLA 刺激细胞内 Ca2+释放(Ca(i)(2+))和 CaMKII 磷酸化,而 c9,t11-CLA 仅对两者均有适度影响。用 BAPTA/AM 螯合 Ca(i)(2+)可消除两种 CLA 异构体对 Akt 底物-160 kDa(AS160)磷酸化和肌管葡萄糖摄取的影响。将肌管暴露于 KN-93 或 autocamtide 2 相关抑制肽以阻止 CaMKII 活性,可防止两种 CLA 异构体诱导 AS160 磷酸化和葡萄糖转运。同样,使用 siRNA 在肌管中基因敲低 CaMKII 完全消除了 CLA 异构体介导的葡萄糖摄取。这些结果表明 CLA 异构体需要 Ca(i)(2+)-CaMKII 来介导葡萄糖摄取。证据表明 CaMKII 抑制剂抑制 t10,c12-CLA 介导的 AMP 激活蛋白激酶(AMPK)激活表明,CaMKII 响应 t10,c12-CLA 在 AMPK 上游起作用。最后,CLA 异构体刺激活性氧的形成,但对应激激活蛋白激酶/c-jun NH2-末端激酶没有影响。这些数据表明,t10,c12-CLA 通过 Ca(i)(2+)-CaMKII-AMPK-AS160 作用刺激骨骼肌葡萄糖转运,而 c9,t11-CLA 的机制尚不清楚。鉴于代谢综合征中肌肉葡萄糖利用受损,阐明 CLA 异构体介导肌肉葡萄糖摄取的分子机制可能为治疗这种疾病提供新的方法。